田军,尚小珂,陈澍,董念国,张长东

• 1:华中科技大学同济医学院附属协和医院心脏大血管外科

摘要(Abstract)：

<正>肺少血型复杂先天性心脏病(如法洛四联症、肺动脉闭锁等)在接受首次矫治手术后常常出现残余肺动脉瓣反流(pulmonary regurgitation,PR),这是此类手术后(尤其是采用了跨环补片修复技术)远期最常见的并发症。严重PR可引起右心室流出道(right ventricular outfl ow tract,RVOT)瘤样扩张和功能障碍、肺动脉瘤样扩张、心室收缩不同步和心律失常、进行性右心室扩张/右心室功能障碍,以及随后的右心衰竭,

关键词(KeyWords)： 法洛四联症;肺动脉瓣反流;右心室流出道;经导管肺动脉瓣置换术

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金(81570325);; 国家重点研发计划(2016YFA0101100);; 湖北省卫健委创新基金(WJ2019M173)

作者(Author): 田军,尚小珂,陈澍,董念国,张长东

参考文献(References)：

• [1]Villafa EJ,Feinstein JA,Jenkins KJ,et al.Hot topics in tetralogy of Fallot.J Am Coll Cardiol,2013,62(23):2155-2166.
• [2]BonhoefferP,Boudjemline Y,Saliba Z,et al.Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction Lancet,2000,356(9239):1403-1405.
• [3]Gales J,Krasuski RA,Fleming GA.Transcatheter valve replacement for right-sided valve disease in congenital heart patients.Prog Cardiovase Dis,2018,61(3-4):347-359.
• [4]Bhagra C.I,Hickey EJ,Alexander VDB,et al.Pulmonary valve procedures late after repair of tetralogy of fallot:current perspectives and contemporary approaches to management.Can J Cardiol,2017,33(9):1138-1149.
• [5]Kim YY,Ruckdeschel E.Approach to residual pulmonary valve dysfunction in adults with repaired tetralogy of Fallot.Heart,2016,102(19):1520-1526.
• [6]Schievano S,Coats L,Migliavacca F,et al.Variations in right ventricular oufflow tract morphology following repair of congenital heart disease:implications for percutaneous pulmonary valve implantation.J Cardiovasc Magn Reson,2007,9(4):687-695.
• [7]Kwak JG,Lee C,Lee M,et aL Does implantation of larger bioprosthetic pulmonary valves in young patients guarantee durability in adults?Durability analysis of stented bioprosthetic valves in the pulmonary position in patients with Tetralogy of Fallot.Eur J CardioThorac Surg,2016,49(4):1207-1212.
• [8]Kheiwa A,Divanji P,Mahadevan VS.Transcatheter pulmonary valve implantation:will it replace surgical pulmonary valve replacement?Expert Rev Cardiovasc Ther,2018,16(3):1-11.
• [9]Ghobrial J,Aboulhosn J.Transcatheter valve replacement in congenital heart disease:The present and the future.Heart,2018,104(19):1629-1636.
• [10]Nordmeyer J,Khambadkone S,Coats L,et al.Risk stratification,systematic classification,and anticipatory management strategies for stent fracture after percutaneous pulmonary valve implantation.Circulation,2007,115(11):1392-1397.
• [11]Qureshi AM,Bansal N,Mcelhinney DB,et al.Branch pulmonary artery valve implantation reduces pulmonary regurgitation and improves right ventricular size/function in patients with large rightventricular oufflow tracts.JACC Cardiovasc Interv.2018,11(6):541-550.
• [12]Zahn EM,Chang JC,Armer D,et al.First human implant of the Alterra Adaptive PrestentTM:A new self-expanding device designed to remodel the right ventricular oufflow tract.Catheter and Cardiovasc Interv,2018,91(6):1125-1129.
• [13]Kenny D,Rhodes IF,Fleming GA,et al.3-year outcomes of the Edwards SAPIEN transcatheter heart valve for conduit failure in the pulmonary position from the compassion multicenter clinical trial.JACC Cardiovasc Interv,2018,11(19):1920-1929.
• [14]Lurz P,Kister T.Why we need another percutaneous pulmonary valve:if size matters.EuroIntervention.2019,14(13):1347-1349.
• [15]Capelli C,Taylor AM,Migliavacca F,et al.Patient-specific reconstructed anatomies and computer simulations are fundamental for selecting medical device treatment:application to a new percutaneous pulmonary valve.Philos Trans A Math Phys Eng Sci,2010,368(1921):3027-3038.
• [16]Schievano S,Taylor AM,Capelli C,et al.First-in-man implantation of a novel percutaneous valve:a new approach to medical device development.Eurointervention,2010,5(6):745-750.
• [17]Bergersen L,Benson LN,Gillespie MJ,et al.Harmony feasibility trial acute and short-term outcomes with a self-expanding transcatheter pulmonary valve.JACC Cardiovasc Interv,2017,10(17):1763-1773.
• [18]Zhou D,Pan W,Jilaihawi H,et al.A self-expanding percutaneous valve for patients with pulmonary regurgitation and an enlarged native right ventricular outflow tract:one-year results.Eurointervention,2018,14(13):1371-1377.
• [19]Beom KG,Kyoung SM,Jung BE,et al.Successful feasibility human trial of a new self-expandable percutaneous pulmonary valve(pulsta valve)implantation using knitted nitinol wire backbone and trileafletα-gal-free porcine pericardial valve in the native right ventricular outflow tract.Circ Cardiovasc Interv,2018,11(6):e006494.
• [20]Shang X,Chen S,Zhang C,et al.First-in-man implantation of med-zenith PT-valve in right ventricular oufflow tract for pulmonary regurgitation.JACC Cardiovasc Interv,2019,12(19):1989-1990.
• [21]Chatterjee A,Bajaj NS,McMahon WS,et al.Transcatheter pulmonary valve implantation:a comprehensive systematic review and meta-analyses of observational studies.J Am Heart Assoc,2017,6(8):e006432.
• [22]Fraisse A,Assaidi A,Mauri L,et al.Coronary artery compression during intention to treat right ventricle outflow with percutaneous pulmonary valve implantation:incidence,diagnosis,and outcome.Catheter Cardiovasc Interv,2014,83(7):E260-E268.
• [23] Stout KK,Daniels CJ,Aboulhosn JA,et al.2018 AHA/ACC Guideline for the management of adults with congenital heart disease.J Am Coll Cardiol,2019,73(12):1494-1563.